Anthracycline cardiomyopathy is mediated by depletion of the cardiac stem cell pool and is rescued by restoration of progenitor cell function
A. De Angelis, E. Piegari, and D. Cappetta Anthracycline cardiomyopathy is mediated by depletion of the cardiac stem cell pool and is rescued by restoration of progenitor cell function Circulation 121 2010 276 292
The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2
B. Yang, H. Lin, and J. Xiao The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2 Nat Med 13 2007 486 491
Role of slow delayed rectifier K+-current in QT prolongation in the alloxan-induced diabetic rabbit heart
C. Lengyel, L. Virag, and P.P. Kovacs Role of slow delayed rectifier K+-current in QT prolongation in the alloxan-induced diabetic rabbit heart Acta Physiol (Oxf) 192 2008 359 368
Protecting the heart against arrhythmias: Potassium current physiology and repolarization reserve
D.M. Roden, and T. Yang Protecting the heart against arrhythmias: potassium current physiology and repolarization reserve Circulation 112 2005 1376 1378
Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by deletion of the p66shc gene
M. Rota, N. LeCapitaine, and T. Hosoda Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by deletion of the p66shc gene Circ Res 99 2006 42 52
Diabetic cardiomyopathy: A "cardiac stem cell disease" involving p66Shc, an attractive novel molecular target for heart failure therapy
E. Messina, and A. Giacomello Diabetic cardiomyopathy: a "cardiac stem cell disease" involving p66Shc, an attractive novel molecular target for heart failure therapy Circ Res 99 2006 1 2